Skip to main content
Total Market Cap: $43,732,033,605 Volume (24h): $739,350,421

Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc. (ARNA) logo
Rank 2
About

Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.

Website
$99.9900
USD
0.00%
Market cap
$4,982,017,948
Total volume
$10,698
Shares outstanding
49,825,162
Rank 2
Website
About

Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
ARNA
$10,698
100%
$99.9900
Chart
Social media
Tweets by @ArenaPharma

Share widget

Copy widget code
Subscribe to our newsletter